Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
HCA Healthcare Pre-Q3 Earnings: Healthy Buy or a Diagnosis to Wait?
HCA's third-quarter earnings are likely to benefit from improved admissions, capacity additions and payer mix, partially offset by rising operating expenses.
Insights Into HCA (HCA) Q3: Wall Street Projections for Key Metrics
Evaluate the expected performance of HCA (HCA) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
HCA Healthcare Q3 Earnings Preview: Step Change In Value (Rating Upgrade)
I previously rated HCA Healthcare a hold due to flat DCF price target of $319 and mixed industry trends. Since my last analysis, industry cost pressures have eased while healthcare spending continues to grow. With additional upside potential and risks mitigated, I raise my rating to buy at a price target of $447.
Prediction: These 2 Stocks Will Beat the S&P 500 Through 2030
There's no need to change a winning formula.
HCA Healthcare (HCA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
HCA (HCA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Will HCA (HCA) Beat Estimates Again in Its Next Earnings Report?
HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
HCA Healthcare: Still A Great Play On Long-Term Growth And Valuation
HCA Healthcare has consistently outperformed the S&P 500, with shares up 43.8% since April 2023 and 66.8% since August 2021. Despite a decline in net income due to asset sales and rising interest expenses, other profitability metrics like operating cash flow and EBITDA have improved. Management's guidance for 2024 anticipates significant revenue and net income growth, with expected revenue between $69.75 billion and $71.75 billion.
3 Hospital Stocks to Buy With Strong Earnings Estimate Revisions
The U.S. hospital industry has been flying high in the past year. Three hospital stocks to buy are: HCA, THC, UHS.
HCA (HCA) Upgraded to Strong Buy: Here's What You Should Know
HCA (HCA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
